INVO Fertility Partners with LEVY Health to Enhance Fertility Training for OB-GYNs
- LEVY Health partners with IVF Academy USA to enhance OB-GYN training in fertility practice through advanced software integration.
- The partnership provides hands-on experience in patient intake and diagnostics, improving training for future fertility specialists.
- LEVY Health's technology supports evidence-based decision-making, equipping trainees with tools to analyze fertility-related biomarkers.
Innovative Partnership to Elevate Fertility Training
In a significant development for reproductive medicine, LEVY Health has inked a partnership with IVF Academy USA aimed at transforming the training of obstetrician-gynecologists (OB-GYNs) venturing into fertility practice. The collaboration, announced on October 6, 2025, integrates LEVY Health’s advanced clinical decision support software into the Academy's curriculum, providing future fertility specialists with critical hands-on experience in patient intake and diagnostics. This initiative addresses the urgent need for enhanced training methods in a field marked by rapid growth and increasing patient demand for fertility services.
The software developed by LEVY Health stands out by efficiently mapping patient histories and lab results to relevant biomarkers, allowing for quicker diagnoses across more than two million possible scenarios. With the ability to analyze up to 120 biomarkers related to fertility and conception, this technology equips trainees with a powerful tool for evidence-based decision-making. Paul Magarelli, MD, PhD, dean of IVF Academy USA, notes that this partnership is pivotal in ensuring that future practitioners have access to the most current medical literature and guidelines, ultimately leading to improved patient outcomes in infertility treatment.
Caroline Mitterdorfer, CEO of LEVY Health, emphasizes the growing necessity for well-trained OB-GYNs in the expanding U.S. fertility care market. The collaboration seeks to cultivate a new generation of fertility providers capable of offering scalable and patient-centered care. By combining LEVY Health’s technological innovations with IVF Academy USA’s commitment to professional education, both organizations are dedicated to enhancing the landscape of fertility care—making advanced training more accessible and effective for healthcare professionals entering this complex field.
In related news, LEVY Health continues to position itself as a leader in reproductive health technology, providing essential diagnostic tools that support healthcare providers. Meanwhile, IVF Academy USA remains focused on equipping physicians with the necessary skills to transition smoothly into fertility practice, underscoring the importance of comprehensive training in meeting the needs of an evolving healthcare environment. Through this partnership, both organizations aim to ensure that the next generation of fertility specialists is well-prepared to meet the challenges and demands of their field. For additional details, visit www.levy.health.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

